Conference Coverage

Psoriatic arthritis treatment: “We’re not doing so well”

Publish date: March 7, 2018

 

EXPERT ANALYSIS FROM RWCS 2018

Pages

Recommended Reading

Arthritis prevalence higher than previously thought, especially in adults under 65
MDedge Internal Medicine
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
MDedge Internal Medicine
FDA approves tofacitinib for psoriatic arthritis
MDedge Internal Medicine
Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Internal Medicine
Meta-analysis: Lifestyle changes improve psoriasis
MDedge Internal Medicine
Make a PEST of your psoriasis patients
MDedge Internal Medicine
Get ready for certolizumab for psoriasis
MDedge Internal Medicine
Here comes bimekizumab, the newest IL-17 inhibitor
MDedge Internal Medicine
Experts review the year in rheumatology ... and what lies ahead
MDedge Internal Medicine
Ustekinumab quells aortic inflammation in patients with severe psoriasis
MDedge Internal Medicine